Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Clinical Investigations

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis*

Rice, Todd W. MD, MSc; Wheeler, Arthur P. MD; Bernard, Gordon R. MD; Vincent, Jean-Louis MD, PhD, FCCM; Angus, Derek C. MD, MPH; Aikawa, Naoki MD, DMSc; Demeyer, Ignace MD; Sainati, Stephen MD, PhD; Amlot, Nicholas MD; Cao, Charlie PhD; Ii, Masayuki PhD; Matsuda, Hideyasu PhD; Mouri, Kouji BSPh; Cohen, Jon MB, FRCP

Author Information
doi: 10.1097/CCM.0b013e3181e7c5c9
  • Buy


© 2010 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins